Stopyra Jason P, Harper William S, Higgins Tyson J, Prokesova Julia V, Winslow James E, Nelson Robert D, Alson Roy L, Davis Christopher A, Russell Gregory B, Miller Chadwick D, Mahler Simon A
1Wake Forest School of Medicine,Winston-Salem,North CarolinaUSA.
2John Peter Smith Hospital,Fort Worth,TexasUSA.
Prehosp Disaster Med. 2018 Feb;33(1):58-62. doi: 10.1017/S1049023X17007154. Epub 2018 Jan 10.
Introduction The History, Electrocardiogram (ECG), Age, Risk Factors, and Troponin (HEART) score is a decision aid designed to risk stratify emergency department (ED) patients with acute chest pain. It has been validated for ED use, but it has yet to be evaluated in a prehospital setting. Hypothesis A prehospital modified HEART score can predict major adverse cardiac events (MACE) among undifferentiated chest pain patients transported to the ED.
A retrospective cohort study of patients with chest pain transported by two county-based Emergency Medical Service (EMS) agencies to a tertiary care center was conducted. Adults without ST-elevation myocardial infarction (STEMI) were included. Inter-facility transfers and those without a prehospital 12-lead ECG or an ED troponin measurement were excluded. Modified HEART scores were calculated by study investigators using a standardized data collection tool for each patient. All MACE (death, myocardial infarction [MI], or coronary revascularization) were determined by record review at 30 days. The sensitivity and negative predictive values (NPVs) for MACE at 30 days were calculated.
Over the study period, 794 patients met inclusion criteria. A MACE at 30 days was present in 10.7% (85/794) of patients with 12 deaths (1.5%), 66 MIs (8.3%), and 12 coronary revascularizations without MI (1.5%). The modified HEART score identified 33.2% (264/794) of patients as low risk. Among low-risk patients, 1.9% (5/264) had MACE (two MIs and three revascularizations without MI). The sensitivity and NPV for 30-day MACE was 94.1% (95% CI, 86.8-98.1) and 98.1% (95% CI, 95.6-99.4), respectively.
Prehospital modified HEART scores have a high NPV for MACE at 30 days. A study in which prehospital providers prospectively apply this decision aid is warranted. Stopyra JP , Harper WS , Higgins TJ , Prokesova JV , Winslow JE , Nelson RD , Alson RL , Davis CA , Russell GB , Miller CD , Mahler SA . Prehospital modified HEART score predictive of 30-day adverse cardiac events. Prehosp Disaster Med. 2018;33(1):58-62.
引言 病史、心电图(ECG)、年龄、危险因素及肌钙蛋白(HEART)评分是一种决策辅助工具,旨在对急诊科(ED)急性胸痛患者进行风险分层。它已在急诊科使用中得到验证,但尚未在院前环境中进行评估。假设 院前改良HEART评分可预测转运至急诊科的未分化胸痛患者的主要不良心脏事件(MACE)。
对由两个县级紧急医疗服务(EMS)机构转运至三级医疗中心的胸痛患者进行回顾性队列研究。纳入无ST段抬高型心肌梗死(STEMI)的成年人。排除机构间转运患者以及没有院前12导联心电图或急诊科肌钙蛋白测量值的患者。研究人员使用标准化数据收集工具为每位患者计算改良HEART评分。所有MACE(死亡、心肌梗死[MI]或冠状动脉血运重建)均通过30天的记录审查确定。计算30天时MACE的敏感性和阴性预测值(NPV)。
在研究期间,794例患者符合纳入标准。30天时,10.7%(85/794)的患者发生MACE,其中12例死亡(1.5%),66例MI(8.3%),12例无MI的冠状动脉血运重建(1.5%)。改良HEART评分将33.2%(264/794)的患者确定为低风险。在低风险患者中,1.9%(5/264)发生MACE(2例MI和3例无MI的血运重建)。30天MACE的敏感性和NPV分别为94.1%(95%CI,86.8 - 98.1)和98.1%(95%CI,95.6 - 99.4)。
院前改良HEART评分对30天MACE具有较高的NPV。有必要开展一项院前提供者前瞻性应用此决策辅助工具的研究。斯托皮拉JP,哈珀WS,希金斯TJ,普罗克索娃JV,温斯洛JE,纳尔逊RD,阿尔森RL,戴维斯CA,拉塞尔GB,米勒CD,马勒SA。院前改良HEART评分可预测30天不良心脏事件。《院前灾难医学》。2018;33(1):58 - 62。